Ginkgo Bioworks DNA Contract Liabilities
Contract Liabilities at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's contract liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ginkgo Bioworks's contract liabilities?
- Ginkgo Bioworks (DNA) reported contract liabilities of $77.9M in Q1 2026.
- How has Ginkgo Bioworks's contract liabilities changed year-over-year?
- Ginkgo Bioworks's contract liabilities decreased by 3.1% year-over-year, from $80.38M to $77.9M.
- What is the long-term trend for Ginkgo Bioworks's contract liabilities?
- Over 4 years (2021 to 2025), Ginkgo Bioworks's contract liabilities has grown at a -20.6% compound annual growth rate (CAGR), from $189.2M to $75.18M.
- What does contract liabilities mean?
- Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.